FDA Inspection 1067019 — Aurident Inc

Aurident Inc — FEI 2023817

The FDA completed an inspection of Aurident Inc on Sep 27, 2018 in Fullerton, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 27, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Fullerton, CA (United States)

Citations

IDCFRDescription
316021 CFR 820.184Lack of or inadequate DHR procedures
333121 CFR 820.181DMR - not or inadequately maintained